Glycan Heterogeneity

Glycan Heterogeneity describes the natural variability in glycan structures attached to glycoproteins produced within biological systems. This microheterogeneity arises from non-template-driven glycosylation processes influenced by cell type, metabolic state, and manufacturing conditions.

The biopharmaceutical industry closely monitors glycan heterogeneity as it directly affects therapeutic consistency, efficacy, and safety. Variability in glycan composition may influence clearance rates, immune recognition, and biological activity. Manufacturing strategies aim to control heterogeneity through cell line selection and process optimisation. Regulatory expectations require demonstrating acceptable glycan variability and consistency across batches. As analytical methods improve enabling more comprehensive glycan profiling, understanding and control of glycan heterogeneity continues advancing in support of consistent, high-quality biologic manufacturing.